The world’s leading predictive test for diabetic kidney disease, the only test capable of predicting onset before clinical symptoms appear
Diabetic kidney disease is the leading cause of chronic and end-stage kidney disease worldwide¹. Most people with diabetic kidney disease do not have symptoms². Prevention is better than cure – transform clinical outcomes.
12th November 2020 - Proteomics inks kidney disease test deal in Mid-East – The West Australian
12th November 2020 - Middle East is next market for PromarkerD immunoassay test
12th November 2020 - Proteomics International Inks Israeli Distribution Deal for Diabetic Kidney Disease Immunoassay – 360Dx
5th November 2020 - PromarkerD clinical assay performance results published
“PromarkerD will save lives and healthcare costs” – Dr Richard Lipscombe to American Diabetes Association (ADA) TV